Skip to content

Cryocompression After Total Knee Arthroplasty

A Randomized Controlled Trial to Evaluate the Effectiveness of Cryocompression After Total Knee Arthroplasty (TKA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05395273
Enrollment
40
Registered
2022-05-27
Start date
2022-05-10
Completion date
2023-09-15
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryotherapy Effect

Brief summary

The overall aim of this study is to evaluate the effectiveness of a cryocompression device after total knee arthroplasty (TKA) compared to standard therapy.

Detailed description

The aim of this study is to investigate the effect of cryocompression after total knee arthroplasty (TKA) compared to a control group without cryocompression. The effect on the following parameters will be evaluated: knee and osteoarthritis outcome score (KOOS), patient satisfaction, knee girth, skin temperature, knee range of motion, morphine consumption, pain perception, the length of stay, the 10-metre walk test and the timed-up-and-go.

Interventions

DEVICEGame Ready cryocompression

Cryotherapy on the coldest tolerable level and intermittend compression on the knee

Sponsors

University of Applied Sciences and Arts of Southern Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Signed Informed Consent * Diagnosed Arthritis of the Knee * Planned implantation of a primary total knee arthroplasty by the Regionalspital Surselva AG

Exclusion criteria

* Decompensated hypertension in the affected area * Acute inflammatory phlebitis in the affected area * Patients with acute paroxysmal cold hemoglobinuria, or cryoglobulinemia * Significant vascular disruption in the affected area * History of pulmonary embolism or risk factors for deep vein thrombosis or pulmonary embolism in the affected area * No increased venous or lymphatic return in the affected leg is desired due to e.g. carcinoma * Raynaud's disease * Hypersensitivity to cold * Fear of cold/compression

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline (preoperatively) Knee and Osteoarthritis Outcome Score (KOOS) at postoperatively (4th day) and 6 weeks after surgerypreoperatively, postoperatively (4th day) and 6 weeks after surgeryA knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems
Change from Baseline (preoperatively) Range of motion at postoperatively (4th day) and 6 weeks after surgerypreoperatively, postoperatively (4th day) and 6 weeks after surgeryRange of motion of the knee
Change from Baseline (preoperatively) Girth at postoperatively (4th day) and 6 weeks after surgerypreoperatively, postoperatively (4th day) and 6 weeks after surgeryKnee girth
Change from Baseline (preoperatively) Timed up and Go at postoperatively (4th day) and 6 weeks after surgerypreoperatively, postoperatively (4th day) and 6 weeks after surgeryA general physical performance test used to assess mobility, balance and locomotor performance
Change from Baseline (preoperatively) Skin temperature at postoperatively (4th day) and 6 weeks after surgerypreoperatively, postoperatively (4th day) and 6 weeks after surgerySkin temperature of the knee
Change from Baseline (preoperatively) Visual analogue scale at postoperatively (4th day) and 6 weeks after surgerypreoperatively, postoperatively (4th day) and 6 weeks after surgeryTo measure the intensity of pain
Change from Baseline (preoperatively) 10 Metre Walk Test at postoperatively (4th day) and 6 weeks after surgerypreoperatively, postoperatively (4th day) and 6 weeks after surgeryTo assess walking speed in meters per second over 10 metres
Change from Baseline (first day postperatively) Patient satisfaction at each day of hospitalisationeach day of hospitalisationTo measure the patient satisfaction of the cryocompression therapy from 0 to 10
Consumption of morphine6 weeks after surgeryConsumption of morphine in number of pills
Length of stay6 weeks after surgeryLength of stay in the hospital in days

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026